LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 71

Search options

  1. Article: Estimated Infection and Vaccine Induced SARS-CoV-2 Seroprevalence in Israel among Adults, January 2020-July 2021.

    Bassal, Ravit / Keinan-Boker, Lital / Cohen, Dani / Mendelson, Ella / Lustig, Yaniv / Indenbaum, Victoria

    Vaccines

    2022  Volume 10, Issue 10

    Abstract: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) emerged in Israel in February 2020 and spread from then. In December 2020, the FDA approved an emergency use authorization of the Pfizer-BioNTech vaccine, and on 20 December, an immunization ... ...

    Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) emerged in Israel in February 2020 and spread from then. In December 2020, the FDA approved an emergency use authorization of the Pfizer-BioNTech vaccine, and on 20 December, an immunization campaign began among adults in Israel. We characterized seropositivity for IgG anti-spike antibodies against SARS-CoV-2 between January 2020 and July 2021, before and after the introduction of the vaccine in Israel among adults. We tested 9520 serum samples, collected between January 2020 and July 2021. Between January and August 2020, seropositivity rates were lower than 5.0%; this rate increased from September 2020 (6.3%) to April 2021 (84.9%) and reached 79.1% in July 2021. Between January and December 2020, low socio-economic rank was an independent, significant correlate for seropositivity. Between January and July 2021, the 40.00-64.99-year-old age group, Jews and others, and residents of the Northern district were significantly more likely to be seropositive. Our findings indicate a slow, non-significant increase in the seropositivity rate to SARS-CoV-2 between January and December 2020. Following the introduction of the Pfizer-BioNTech vaccine in Israel, a significant increase in seropositivity was observed from January until April 2021, with stable rates thereafter, up to July 2021.
    Language English
    Publishing date 2022-10-05
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2703319-3
    ISSN 2076-393X
    ISSN 2076-393X
    DOI 10.3390/vaccines10101663
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Measles outbreak associated with a preschool setting among partially vaccinated children in the Tel Aviv District, Israel, October 2023.

    Sheffer, Rivka / Bucris, Efrat / Amitai, Ziva / Indenbaum, Victoria / Lustig, Yaniv / Savion, Michal / Nuss, Naama / Roee Singer, Shepherd / Alroy Preis, Sharon / Almagor, Sharon / Leshem, Eyal / Salama, Matanelle

    Vaccine

    2024  Volume 42, Issue 13, Page(s) 3153–3156

    Abstract: In October 2023, the Tel Aviv District was notified of ten cases of measles. The outbreak initiated in a preschool with high vaccination coverage with one dose of MMR vaccine. Serological testing was available for eight patients (six children and two ... ...

    Abstract In October 2023, the Tel Aviv District was notified of ten cases of measles. The outbreak initiated in a preschool with high vaccination coverage with one dose of MMR vaccine. Serological testing was available for eight patients (six children and two adults). Among the six children vaccinated with one dose of MMR vaccine, primary vaccine failure was demonstrated. Among the adults, secondary vaccine failure was confirmed. The outbreak was successfully contained due to a combination of factors, notably its occurrence within a population characterized by high vaccination coverage in Tel Aviv, during a period of restricted public interactions due to the prevailing state of war in the country. Despite challenging wartime conditions, effective prophylactic measures were promptly executed, encompassing a 2-dose MMR vaccination schedule for close contacts and the broader community of children in the TA district, successfully curbing the outbreak and preventing widespread infections.
    MeSH term(s) Humans ; Measles/prevention & control ; Measles/epidemiology ; Disease Outbreaks/prevention & control ; Israel/epidemiology ; Child, Preschool ; Measles-Mumps-Rubella Vaccine/administration & dosage ; Measles-Mumps-Rubella Vaccine/immunology ; Male ; Female ; Adult ; Vaccination/statistics & numerical data ; Vaccination Coverage/statistics & numerical data ; Child ; Infant ; Immunization Schedule ; Adolescent ; Young Adult
    Chemical Substances Measles-Mumps-Rubella Vaccine
    Language English
    Publishing date 2024-04-15
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 605674-x
    ISSN 1873-2518 ; 0264-410X
    ISSN (online) 1873-2518
    ISSN 0264-410X
    DOI 10.1016/j.vaccine.2024.04.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022- and 2023.

    Lustig, Yaniv / Canetti, Michal / Indenbaum, Victoria / Peretz, Yovel / Weiss-Ottolenghi, Yael / Margalit, Ili / Asraf, Keren / Levin, Tal / Zuckerman, Neta / Tomer, Enosh / Mandelboim, Michal / Doolman, Ram / Barda, Noam / Regev-Yochay, Gili

    Emerging infectious diseases

    2024  Volume 30, Issue 5, Page(s) 1050–1052

    Abstract: Although a vaccine against SARS-CoV-2 Omicron-XBB.1.5 variant is available worldwide and recent infection is protective, the lack of recorded infection data highlights the need to assess variant-specific antibody neutralization levels. We analyzed IgG ... ...

    Abstract Although a vaccine against SARS-CoV-2 Omicron-XBB.1.5 variant is available worldwide and recent infection is protective, the lack of recorded infection data highlights the need to assess variant-specific antibody neutralization levels. We analyzed IgG levels against receptor-binding domain-specific SARS-CoV-2 ancestral strain as a correlate for high neutralizing titers against XBB variants.
    MeSH term(s) Humans ; Immunoglobulin G/blood ; Immunoglobulin G/immunology ; SARS-CoV-2/immunology ; SARS-CoV-2/genetics ; COVID-19/immunology ; COVID-19/epidemiology ; COVID-19/prevention & control ; Antibodies, Neutralizing/immunology ; Antibodies, Neutralizing/blood ; Antibodies, Viral/blood ; Antibodies, Viral/immunology ; Israel/epidemiology ; Spike Glycoprotein, Coronavirus/immunology ; Spike Glycoprotein, Coronavirus/genetics ; COVID-19 Vaccines/immunology ; Male ; Adult ; Middle Aged ; Female ; Aged ; Neutralization Tests
    Chemical Substances Immunoglobulin G ; Antibodies, Neutralizing ; Antibodies, Viral ; Spike Glycoprotein, Coronavirus ; COVID-19 Vaccines
    Language English
    Publishing date 2024-04-26
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1380686-5
    ISSN 1080-6059 ; 1080-6040
    ISSN (online) 1080-6059
    ISSN 1080-6040
    DOI 10.3201/eid3005.231739
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Does the SARS-CoV-2 mRNA vaccine and its serum IgG levels affect fertility treatments and obstetric outcomes? An observational cohort study.

    Miller, Netanella Danielli / Goren Gepstein, Nitzan / Cohen, Dovev / Haikin Herzberger, Einat / Shalev Ram, Hila / Mashiach Friedler, Jordana / Sharon Weiner, Maya / Rahav, Roni / Indenbaum, Victoria / Lustig, Yaniv / Wiser, Amir

    Clinical and experimental medicine

    2024  Volume 24, Issue 1, Page(s) 81

    Abstract: Background: Although there are some data regarding the COVID-19 vaccine and in in vitro fertilization (IVF) treatments, its potential impact in terms of serum immunoglobulin G (IgG) levels has not been evaluated prospectively. This study aimed to assess ...

    Abstract Background: Although there are some data regarding the COVID-19 vaccine and in in vitro fertilization (IVF) treatments, its potential impact in terms of serum immunoglobulin G (IgG) levels has not been evaluated prospectively. This study aimed to assess the effect of COVID-19 vaccine and IgG levels on IVF outcomes.
    Methods: This observational, cohort study was conducted at a referral IVF unit. Couples undergoing IVF treatment during the COVID-19 vaccination period were recruited from March-April 2021. The study compared 38 women who had received the Pfizer mRNA COVID-19 vaccination to 10 women who had not and were not infected by the virus. We also compared pre- and post-vaccination IVF treatments for 24 women. The relation between serologic titers and IVF treatment outcomes was also assessed.
    Results: No significant difference was found between the vaccinated and unvaccinated/uninfected groups regarding the main outcome measures. However, there was a trend toward a higher pregnancy rate for the unvaccinated group (57% vs. 23%, p = 0.078) but no difference in delivery rate (p = 0.236), gestational week (p = 0.537) or birth rate (p = 0.671).
    Conclusion: We cautiously state that the COVID-19 mRNA vaccine does not affect fertility outcomes, including fertilization, pregnancy and delivery rates, obstetric outcomes, and semen parameters, regardless of measured IgG levels.
    MeSH term(s) Humans ; Female ; Immunoglobulin G/blood ; Pregnancy ; Adult ; Fertilization in Vitro ; COVID-19/prevention & control ; COVID-19/immunology ; COVID-19 Vaccines/immunology ; COVID-19 Vaccines/administration & dosage ; SARS-CoV-2/immunology ; Cohort Studies ; Male ; Pregnancy Rate ; Antibodies, Viral/blood ; mRNA Vaccines
    Chemical Substances Immunoglobulin G ; COVID-19 Vaccines ; Antibodies, Viral ; mRNA Vaccines
    Language English
    Publishing date 2024-04-23
    Publishing country Italy
    Document type Journal Article ; Observational Study
    ZDB-ID 2053018-3
    ISSN 1591-9528 ; 1591-8890
    ISSN (online) 1591-9528
    ISSN 1591-8890
    DOI 10.1007/s10238-024-01345-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Humoral Immunity of Unvaccinated COVID-19 Recovered vs. Naïve BNT162b2 Vaccinated Individuals: A Prospective Longitudinal Study.

    Joseph, Gili / Cohen, Carmit / Rubin, Carmit / Murad, Havi / Indenbaum, Victoria / Asraf, Keren / Weiss-Ottolenghi, Yael / Segal-Lieberman, Gabriella / Kreiss, Yitshak / Lustig, Yaniv / Regev-Yochay, Gili

    Microorganisms

    2023  Volume 11, Issue 7

    Abstract: To study the differences in the immune response to SARS-CoV-2 infection compared to the response to vaccination, we characterized the humoral immune kinetics of these situations. In this prospective longitudinal study, we followed unvaccinated COVID-19- ... ...

    Abstract To study the differences in the immune response to SARS-CoV-2 infection compared to the response to vaccination, we characterized the humoral immune kinetics of these situations. In this prospective longitudinal study, we followed unvaccinated COVID-19-recovered individuals (
    Language English
    Publishing date 2023-06-22
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2720891-6
    ISSN 2076-2607
    ISSN 2076-2607
    DOI 10.3390/microorganisms11071628
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Highly Sensitive and Specific SARS-CoV-2 Serological Assay Using a Magnetic Modulation Biosensing System.

    Avivi-Mintz, Shira / Lustig, Yaniv / Indenbaum, Victoria / Schwartz, Eli / Danielli, Amos

    Biosensors

    2021  Volume 12, Issue 1

    Abstract: Sensitive serological assays are needed to provide valuable information about acute and past viral infections. For example, detection of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG antibodies could serve as the basis for an " ... ...

    Abstract Sensitive serological assays are needed to provide valuable information about acute and past viral infections. For example, detection of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG antibodies could serve as the basis for an "immunity passport" that would enable individuals to travel internationally. Here, utilizing a novel Magnetic Modulation Biosensing (MMB) system and the receptor-binding domain of the SARS-CoV-2 spike protein, we demonstrate a highly sensitive and specific anti-SARS-CoV-2 IgG serological assay. Using anti-SARS-CoV-2 IgG antibodies, RT-qPCR SARS-CoV-2-positive and healthy patients' samples, and vaccinees' samples, we compare the MMB-based SARS-CoV-2 IgG assay's analytical and clinical sensitivities to those of the enzyme-linked immunosorbent assay (ELISA). Compared with ELISA, the MMB-based assay has an ~6-fold lower limit of detection (129 ng/L vs. 817 ng/L), and it detects an increase in the IgG concentration much earlier after vaccination. Using 85 RT-qPCR SARS-CoV-2-positive samples and 79 -negative samples, the MMB-based assay demonstrated similar clinical specificity (98% vs. 99%) and sensitivity (93% vs. 92%) to the ELISA test, but with a much faster turnaround time (45 min vs. 245 min). The high analytical and clinical sensitivity, short turnaround time, and simplicity of the MMB-based assay makes it a preferred method for antibody detection.
    MeSH term(s) Antibodies, Viral/analysis ; Biosensing Techniques ; COVID-19/diagnosis ; COVID-19/immunology ; Enzyme-Linked Immunosorbent Assay ; Humans ; Immunoglobulin G/analysis ; Magnetic Phenomena ; SARS-CoV-2/immunology ; Sensitivity and Specificity ; Serologic Tests ; Spike Glycoprotein, Coronavirus
    Chemical Substances Antibodies, Viral ; Immunoglobulin G ; Spike Glycoprotein, Coronavirus ; spike protein, SARS-CoV-2
    Language English
    Publishing date 2021-12-23
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662125-3
    ISSN 2079-6374 ; 2079-6374
    ISSN (online) 2079-6374
    ISSN 2079-6374
    DOI 10.3390/bios12010007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up.

    Canetti, Michal / Barda, Noam / Gilboa, Mayan / Indenbaum, Victoria / Mandelboim, Michal / Gonen, Tal / Asraf, Keren / Weiss-Ottolenghi, Yael / Amit, Sharon / Doolman, Ram / Mendelson, Ella / Harats, Dror / Freedman, Laurence S / Kreiss, Yitshak / Lustig, Yaniv / Regev-Yochay, Gili

    Nature communications

    2023  Volume 14, Issue 1, Page(s) 1593

    Language English
    Publishing date 2023-03-22
    Publishing country England
    Document type Published Erratum
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-023-37338-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Six-Month Follow-up after a Fourth BNT162b2 Vaccine Dose.

    Canetti, Michal / Barda, Noam / Gilboa, Mayan / Indenbaum, Victoria / Asraf, Keren / Gonen, Tal / Weiss-Ottolenghi, Yael / Amit, Sharon / Doolman, Ram / Mendelson, Ella / Freedman, Laurence S / Kreiss, Yitshak / Lustig, Yaniv / Regev-Yochay, Gili

    The New England journal of medicine

    2022  Volume 387, Issue 22, Page(s) 2092–2094

    MeSH term(s) Humans ; Antibodies, Viral/immunology ; BNT162 Vaccine/immunology ; BNT162 Vaccine/therapeutic use ; Follow-Up Studies ; COVID-19/immunology ; COVID-19/prevention & control ; Immunization, Secondary
    Chemical Substances Antibodies, Viral ; BNT162 Vaccine
    Language English
    Publishing date 2022-11-09
    Publishing country United States
    Document type Letter
    ZDB-ID 207154-x
    ISSN 1533-4406 ; 0028-4793
    ISSN (online) 1533-4406
    ISSN 0028-4793
    DOI 10.1056/NEJMc2211283
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Waning humoral immune response to the BNT162b2 vaccine in heart transplant recipients over 6 months.

    Peled, Yael / Ram, Eilon / Mandelboim, Michal / Lavee, Jacob / Sternik, Leonid / Segev, Amit / Wieder-Finesod, Anat / Halperin, Rebecca / Indenbaum, Victoria / Levy, Itzchak / Patel, Jignesh / Raanani, Ehud / Lustig, Yaniv / Rahav, Galia

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

    2022  Volume 22, Issue 7, Page(s) 1931–1932

    MeSH term(s) Antibodies, Viral ; BNT162 Vaccine ; Heart Transplantation ; Humans ; Immunity, Humoral ; Influenza Vaccines ; Transplant Recipients
    Chemical Substances Antibodies, Viral ; Influenza Vaccines ; BNT162 Vaccine (N38TVC63NU)
    Language English
    Publishing date 2022-03-01
    Publishing country United States
    Document type Letter
    ZDB-ID 2060594-8
    ISSN 1600-6143 ; 1600-6135
    ISSN (online) 1600-6143
    ISSN 1600-6135
    DOI 10.1111/ajt.16998
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Under-diagnosis of SARS-CoV-2 infections among children aged 0-15 years, a nationwide seroprevalence study, Israel, January 2020 to March 2021.

    Indenbaum, Victoria / Lustig, Yaniv / Mendelson, Ella / Hershkovitz, Yael / Glatman-Freedman, Aharona / Keinan-Boker, Lital / Bassal, Ravit

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

    2021  Volume 26, Issue 48

    Abstract: Until recently, children and adolescents were not eligible for COVID-19 vaccination. They may have been a considerable source of SARS-CoV-2 spread. We evaluated SARS-CoV-2 IgG antibody seroprevalence in Israeli children aged 0-15 years from January 2020 ... ...

    Abstract Until recently, children and adolescents were not eligible for COVID-19 vaccination. They may have been a considerable source of SARS-CoV-2 spread. We evaluated SARS-CoV-2 IgG antibody seroprevalence in Israeli children aged 0-15 years from January 2020 to March 2021. Seropositivity was 1.8-5.5 times higher than COVID-19 incidence rates based on PCR testing. We found that SARS-CoV-2 infection among children is more prevalent than previously thought and emphasise the importance of seroprevalence studies to accurately estimate exposure.
    MeSH term(s) Adolescent ; Antibodies, Viral ; COVID-19 ; COVID-19 Vaccines ; Child ; Humans ; Israel/epidemiology ; SARS-CoV-2 ; Seroepidemiologic Studies
    Chemical Substances Antibodies, Viral ; COVID-19 Vaccines
    Language English
    Publishing date 2021-12-02
    Publishing country Sweden
    Document type Journal Article
    ZDB-ID 1338803-4
    ISSN 1560-7917 ; 1025-496X
    ISSN (online) 1560-7917
    ISSN 1025-496X
    DOI 10.2807/1560-7917.ES.2021.26.48.2101040
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top